We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

311 hedge funds and large institutions have $3.72B invested in Editas Medicine in 2020 Q4 according to their latest regulatory filings, with 104 funds opening new positions, 87 increasing their positions, 69 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

235% more first-time investments, than exits

New positions opened: 104 | Existing positions closed: 31

140% more capital invested

Capital invested by funds: $1.55B → $3.72B (+$2.17B)

40% more call options, than puts

Call options by funds: $188M | Put options by funds: $134M

30% more funds holding

Funds holding: 239 → 311 (+72)

26% more repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 69

3.56% less ownership

Funds ownership: 88.57% → 85.02% (-3.6%)

Holders
311
Holders Change
+72
Holders Change %
+30.13%
% of All Funds
5.5%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
104
Increased
87
Reduced
69
Closed
31
Calls
$188M
Puts
$134M
Net Calls
+$53.9M
Net Calls Change
+$35M

Top Buyers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$16.8M
2
Voloridge Investment Management
Voloridge Investment Management
Florida
+$16.7M
3
GLA
Great Lakes Advisors
Illinois
+$15.6M
4
SOMRS
State of Michigan Retirement System
Michigan
+$12.6M
5
JP Morgan Chase
JP Morgan Chase
New York
+$5.13M

Top Sellers

Rank Fund Capital Flow
1
NAMA
Nikko Asset Management Americas
New York
-$28.2M
2
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
-$28.2M
3
State Street
State Street
Massachusetts
-$26.4M
4
AIM
ARK Investment Management
Florida
-$22.4M
5
DM
Deerfield Management
New York
-$18.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
OPW
301
Oxler Private Wealth
New York
$3K +$2.05K +50 New
AIG
302
American International Group
New York
$2.56K -$43K -1,047 -3%
LC
303
Lindbrook Capital
California
$2K – – –
TWA
304
TCI Wealth Advisors
Arizona
$2K – – –
EI
305
Ellevest Inc
New York
$2K +$452 +11 +61%
CAAS
306
Capital Asset Advisory Services
Michigan
$2K +$1.23K +30 New
IA
307
IFP Advisors
Florida
$1K – – –
QCG
308
Quadrant Capital Group
Ohio
$1K – – –
CWA
309
Clearview Wealth Advisors
Oregon
$1K +$411 +10 New
AWA
310
Arkadios Wealth Advisors
Georgia
$1K +$781 +19 New
ECM
311
Estabrook Capital Management
New York
$911 – – –
Renaissance Technologies
312
Renaissance Technologies
New York
– -$2.98M -106,100 Closed
TW
313
TrinityPoint Wealth
Connecticut
– -$1.07M -38,047 Closed
Capital Fund Management (CFM)
314
Capital Fund Management (CFM)
France
– -$903K -32,166 Closed
SFI
315
Susquehanna Fundamental Investments
Pennsylvania
– -$803K -28,600 Closed
DA
316
Duality Advisers
Florida
– -$686K -24,460 Closed
Man Group
317
Man Group
United Kingdom
– -$578K -20,610 Closed
PP
318
PDT Partners
New York
– -$541K -19,279 Closed
BWM
319
BNC Wealth Management
Oregon
– -$526K -18,738 Closed
EGM
320
Engineers Gate Manager
New York
– -$492K -17,544 Closed
Qube Research & Technologies (QRT)
321
Qube Research & Technologies (QRT)
United Kingdom
– -$480K -17,108 Closed
HSBC Holdings
322
HSBC Holdings
United Kingdom
– -$374K -13,178 Closed
Group One Trading
323
Group One Trading
Illinois
– -$535K -13,021 Closed
WCM
324
Weld Capital Management
New York
– -$349K -12,445 Closed
FAIM
325
Financial Advocates Investment Management
Washington
– -$309K -11,000 Closed
10 11 12
13
14

EDIT Hedge Fund Activity: Q4 2020 in Review

311 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2020, worth a combined $3.72B — up 140% from $1.55B a quarter earlier.

Buyers outnumbered sellers: 104 funds opened new EDIT positions and 31 closed out — a net gain of 73 holders — while 87 added to existing stakes and 69 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $16.8M. The largest seller was Nikko Asset Management Americas, cutting an estimated $28.2M.

  • 311 institutional investors held Editas Medicine (EDIT) as of Q4 2020, up from 239 in Q3 2020.
  • Funds reported $3.72B of Editas Medicine stock for Q4 2020, up 140% quarter-over-quarter.
  • 104 funds opened new Editas Medicine positions in Q4 2020 and 31 closed out, a net change of +73 holders.
  • The largest Editas Medicine buyer in Q4 2020 was D.E. Shaw & Co, an estimated $16.8M added.
  • The largest Editas Medicine seller in Q4 2020 was Nikko Asset Management Americas, an estimated $28.2M sold.

Based on aggregated 13F filings for Q4 2020.